Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Industry Hotspot | General Manager Wang Xiaoya Awarded “2022 Leader in China’s In Vitro Diagnostic Industry”

Continue reading
06 2 月

Common Molecular Marker for Glioma: ATRX

Continue reading
06 2 月

Pandemic Can’t Dampen Passion, Maxin Satellite Brings You Exclusive “New” Surprises

Continue reading
06 2 月

Pathology Diagnosis Pitfalls: Plasmablastic Lymphoma May Express CK

Continue reading
06 2 月

Beware! The Pure Scattered Punctate Nuclear Staining Pattern of MLH1!

Continue reading
06 2 月

Focus on the Two Sessions: National Committee Member Bian Xiuwu Highlights Pathology’s Unique Role in Pandemic Response

Continue reading
06 2 月

Prognostic Indicators for Colorectal Cancer

Continue reading
06 2 月

Immunodiagnostic Approach for Adult Renal Epithelial Cell Tumors

Continue reading
06 2 月

Fuzhou Maixin Sends Prayers for Wenchuan

Continue reading
06 2 月

MaxVisionTM 3/HRP Immunohistochemistry Staining Protocol

Continue reading
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar